MAR 6, 2015
The spectacular growth of the Boston area’s life sciences sector has had a vital source: the National Institutes of Health, a lifeline of basic research funding…The funding spigot, however, is being tightened. In the past decade, NIH grants have lost ground against the cost of doing research.
…
Warren’s plan, endorsed by nearly 30 national and local medical associations, is to bolster NIH funding by siphoning a small percentage of profits from big drug companies whose blockbuster drugs can be traced to federal funding – but only when they violate laws.
…
Her proposal is a creative, sensible solution to boost NIH funding, and Congress should approve it.
Read the full editorial here.